Health · Healthcare & Policy · 16 hrs ago

Latin American health leaders urge Korea to share technology, not just aid

Latin American health leaders urge Korea to share technology, not just aid

Health leaders in Brazil and Latin America want partnerships that build local capacity, rather than aid that simply supplies finished medicines and equipment.

The COVID-19 pandemic exposed how vulnerable countries can be when medicine supply chains fail, and many now want to produce more health products themselves.

Brazil aims to raise domestic production of key health products to 70% by 2033 and requires technology transfer and joint production for some companies seeking access to its public health market.

Regional health groups also want Korean companies to work with local partners on diagnostic tests, including tests for diseases that are hard to diagnose in low-resource settings.

In Rio de Janeiro’s Rocinha neighborhood, a shorter tuberculosis treatment program helped raise treatment completion from below 50% to more than 95%.

The leaders say Korea’s diagnostic and biotech expertise could support local health systems, while giving Korean firms a role in shared production and research.

With Korea set to lead the G20 in 2028, they want it to make global health cooperation, chronic disease care and continued health funding priorities.

1 source

Related

What people are saying

Priscila Ferraz SoaresVice president for health production and innovation at Fiocruz
Multinational pharmaceutical companies must transfer technology to local institutions and engage in joint production to enter Brazil’s large public procurement market (SUS).
via Yonhap
Sergio Sosa-EstaniHead of DNDi’s Latin America office
If you develop a treatment but have no diagnostic equipment to accurately identify patients in the field, it is useless.
via Yonhap
Draurio Barreira Cravo NetoDirector of DATHI at Brazil’s Ministry of Health
For medical innovation to reach patients, innovation in point-of-care testing devices is urgently needed, and the excellent technology of Korean companies can fill this gap.
via Yonhap
Kimberly GreenDirector of PATH’s primary health care program
South Korea, with its rich experience in chronic disease management and strengthening primary health care, should bring this issue to the forefront at the 2028 G20.
via Yonhap